Literature DB >> 15542449

Expression of an interleukin-6 - interleukin-2 fusion protein (pIL-6-IL-2) in P. pastoris.

Yan Lin1, Qin Ya-Li, Bei Wei-Cheng, Yu Xiao-Lan, Huang Hong-Liang, Chen Huan-Chun.   

Abstract

Interleukin-2 and interleukin-6 can stimulate the growth and proliferation of T lymphocytes and the differentiation of activated B lymphocytes respectively, and in turn enhance cellular and humoral immune responses. In this work, an expression clone using Pichia pastoris, a methylotrophic yeast strain, has been developed in order to produce large amounts of the functional recombinant fusion protein pIL-6-IL-2, which contains the mature porcine interleukin-6 peptide and the mature porcine interleukin-2 peptide. Two components of the fusion protein were connected by means of a flexible linker (Gly-Gly-Gly-Gly-Ser-Glu-Phe-Gly-Ser-Gly-Gly). In response to 1% methanol induction, the recombinant strain GS115\9K-IL6-IL2 secreted an exogenous protein, with a molecular weight of approximately 40 kD, into the culture medium. This was confirmed to be pIL-6-IL-2 by means of SDS-PAGE and Western Blot analysis. The protein was visible on the 2nd day following methanol induction, and peaked on the 4th day. By this time, the level had reached 50 mg\L as determined using the method of Bradford. After treatment with PNGase F and analysis of the concentration of sugar, the fusion protein pIL-6-IL-2 was further confirmed to be mainly a glycoprotein with an approximately 2 kDa sugar decoration. In addition, the IL-6 and IL-2 biological activities of the fusion protein, determined by cell proliferation assays using the IL6-dependent cell line B9 and the IL2-dependent cell line CTLL-2, reached 1 x 10(5) U\mg and 8 x 10(5) U\mg, respectively. This report is the first description of fused porcine cytokines expressed in P. pastoris, which might be an interesting adjuvant product for veterinary vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542449

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  2 in total

1.  Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production.

Authors:  Guangying Du; Liang Ye; Guoying Zhang; Qiuju Dong; Kun Liu; Jingwei Tian
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-15       Impact factor: 4.553

2.  BglBricks: A flexible standard for biological part assembly.

Authors:  J Christopher Anderson; John E Dueber; Mariana Leguia; Gabriel C Wu; Jonathan A Goler; Adam P Arkin; Jay D Keasling
Journal:  J Biol Eng       Date:  2010-01-20       Impact factor: 4.355

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.